Meningioma is the most common intracranial tumor, with limited treatment options. In order to identify new therapies for meningioma, it is important to understand their underlying biology. In this Share Your Research talk, Dr. Abrar Choudhury describes his thesis research, which began by looking at DNA methylation patterns to better understand gene regulation in meningioma, leading him to identify the cell cycle proteins CDK4 and CDK6 as therapeutic targets.
Abrar Choudhury completed his PhD in Biomedical Sciences at UCSF, and will receive his MD from UCSF in 2023. He studies the underlying biology of brain tumors with the goal of identifying novel therapeutic targets. https://twitter.com/abrarchttps://raleighlab.ucsf.edu/raleigh-laboratory Continue Reading